289
Participants
Start Date
September 18, 2014
Primary Completion Date
June 30, 2016
Study Completion Date
June 22, 2017
Cenicriviroc
CVC 150 mg, administered orally once daily and taken every morning with food.
Placebo
Placebo administered orally once daily and taken every morning with food.
Brussels
Brussels
Garran
Edegem
Leuven
Melbourne
Heidelberg
Heidelberg
Clayton
Herston
Adelaide
Bedford Park
Perth
New York
Berlin
Buffalo
Rozzano
Milan
Hamburg
Chevy Chase
Lutherville
Baltimore
Baltimore
Richmond
Lübeck
Winston-Salem
Raleigh
Durham
Madrid
Hanover
Toulouse
Miami
Pessac
Tampa
Montpellier
Marburg
Dothan
Chattanooga
Germantown
Tupelo
Flowood
Bologna
Louisville
Cincinnati
Ann Arbor
Angers
Cologne
Aachen
Vandœuvre-lès-Nancy
Saint Paul
Chicago
Heidelberg
Lyon
New Orleans
Paris
Paris
Houston
San Antonio
Live Oak
San Antonio
Houston
Littleton
Salt Lake City
Phoenix
Tucson
Palermo
San Diego
San Diego
Rialto
San Francisco
Villejuif
Seattle
Boston
Worcester
Jackson
Shatin
Leipzig
Chorzów
Mysłowice
Lodz
Rzeszów
Wroclaw
Alicante
Barcelona
Barcelona
Barcelona
Portsmouth
London
London
Newcastle
Nottingham
Tobira Therapeutics, Inc.
INDUSTRY